Company dissolved

Nuvectra is a medical device company that specializes in neuromodulation technology aimed at treating chronic neurological conditions, particularly chronic pain. The company focuses on developing and commercializing neurostimulation platforms, including Spinal Cord Stimulation (SCS), Sacral Neuromodulation (SNM), and Deep Brain Stimulation (DBS). The flagship product, the Algovita® Spinal Cord Stimulation System, is designed for chronic pain management and received FDA premarket approval in November 2015. It has been commercially available in the U.S. since early 2016 and has also obtained CE mark approval for use in Europe. Nuvectra actively promotes Algovita through physician training and participation in industry events, targeting healthcare providers such as hospitals and pain management specialists in both the U.S. and European markets.

• Employees 16
• Founded 2016